Several organizations collaborate to create a standardized tool to screen allogeneic hematopoietic progenitor cell (HPC) donors for communicable disease risk factors in accordance with the requirements of the Food and Drug Administration (FDA), FACT, AABB, and the National Marrow Donor Program (NMDP). Both the HPC and cord blood questionnaires were recently revised to include recommendations made by the FDA’s Guidance for Industry: Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products, published this month.

When implementing the revised questionnaire and related materials, comply with established change control processes, including document control and personnel training. Changes made to the materials are listed in accompanying charts.

Download the Donor History Questionnaire for Allogeneic HPC, Apheresis and HPC, Marrow – Version 1.5 March 2016

Download the Donor History Questionnaire for HPC, Cord Blood – Version 1.2 March 2016

Ask FACT

FAQ

FACT Consulting

Accreditation Success Story

Hospital Israelita Albert Einstein (HIAE) in Brazil is the first Bone Marrow Transplantation Center in Latin America to receive FACT accreditation. HIAE is accredited for autologous and allogenic transplantation. Read more